Kaposi's Sarcoma in Association with Behcet's Disease: Case Report and Literature Review

Seminars in Arthritis and Rheumatism

Volumn 36, Issue 5, 2007, Pages 328-331

  Mezalek, Z Tazi ^a   Harmouche, H ^a   Attar, N El ^a   Serraj, K ^a   Aouni, M ^a   Adnaoui, M ^a   Maaouni, A ^a  

^a IBN SINA HOSPITAL   (Morocco)

Author keywords

Behcet's disease; corticosteroids; HHV8; Kaposi's sarcoma

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; MOROCCO; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; UVEITIS; VIRUS REACTIVATION;

ADULT; ANTIVIRAL AGENTS; BEHCET SYNDROME; CYCLOPHOSPHAMIDE; FATAL OUTCOME; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; INTERFERON-ALPHA; MALE; SARCOMA, KAPOSI;

EID: 34047207470     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2006.11.001     Document Type: Article

References (21)

1. Martin R.W., Hood A.F., and Farmer E.R. Kaposi sarcoma. Medicine 72 (1993) 245-261
2. Trathner A., Hodak E., David M., and Sandbank M. The appearance of Kaposi's sarcoma during corticosteroid therapy. Cancer 72 (1993) 1779-1783
3. Louthrenoo W., Kasitanon N., Mahanuphab P., Bhoopat L., and Thongprasert S. Kaposi's sarcoma in rheumatic disease. Semin Arthritis Rheum 32 (2003) 326-333
4. Kötter I., Aepinus C., Graepler F., Gartner V., Eckstein A.K., Stubiger N., et al. HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cycloporin A, azathioprine and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon α. Ann Rheum Dis 60 (2001) 83-86
5. International Study Group for Behcet's Disease. Criteria for the diagnosis of Behcet's disease. Lancet 335 (1990) 1078-1080
6. Moosa M.R. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine 84 (2005) 12-22
7. El Maghraoui A., Sekkach Y., Quacif H., Abouzahir A., Ghafir D., Ohayon V., et al. Iatrogenic Kaposi's sarcoma following immunosuppressive therapy for systemic lupus erythematosus. Clin Exp Rheumatol 21 (2003) 674
8. Ouazzani B., Benchekroun N., El Aouni A., Hajji Z., Chaoui Z., and Berraho-Hamani A. Outcome of Behcet disease in ophthalmologic practice in Morocco. J Fr Ophthalmol 18 (1995) 373-375
9. Hbid O., Belloul L., Fajali N., Ismaili N., Duprez R., Tanguy M., et al. Kaposi's sarcoma in Morocco: a pathological study with immunostaining for human herpesvirus-8 LNA-1. Pathology 37 (2005) 288-295
10. Erban S.B., and Sokas R.K. Kaposi's sarcoma in an elderly man with Wegener's granulomatosis treated with cyclophosphamide and corticosteroids. Arch Intern Med 148 (1988) 1201-1203
11. Deschesnes I., Dion L., Beauchesne C., and de Brum-Fernandes A.J. Kaposi's sarcoma following immune suppressive therapy for Wegener's Granulomatosis. J Rheumatol 30 (2003) 622-624
12. Goedert J.J., Vitale F., Lauria C., Serraino D., Tamburini M., Montella M., et al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 94 (2002) 1712-1720
13. Martin J.N. Diagnosis and epidemiology of human herpesvirus 8 infection. Semin Hematol 40 (2003) 133-142
14. Kassimi B.E., Benchemsi N., Mikou O., Ouazzani E.E., and Lakhdar H. Kaposi's sarcoma and anti-herpes virus 8 antibodies in Morocco. Med Malad Infect 33 (2003) 226-228
15. Guo W.X., and Antakly T. AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucorticoid on cell proliferation. Am J Pathol 146 (1995) 727-734
16. Guo W.X., Antakly T., Cadotte M., Kachra Z., Kunkel L., Masood R., et al. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma. Am J Pathol 148 (1996) 1999-2008
17. Hudnall S.D., Rady P.L., Tyring S.K., and Fish J.C. Hydrocortisone activation of human herpes virus 8 viral DNA replication and gene expression in vitro. Transplantation 67 (1999) 648-652
18. Zoeteweij J.P., Rinderknecht A.S., Davis D.A., Yarchoan R., and Blauvelt A. Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines. J Med Virol 66 (2002) 378-383
19. Kötter I., Günaydin I., Zierhut M., and Stübiger N. The use of interferon α in Behcet disease. Review of the literature. Semin Arthritis Rheum 33 (2004) 320-335
20. Strohal R., Tshachler E., Breyer S., Uthman A., Simonitsch I., Tratting S., et al. Reactivation of Behcet's disease in the course of multicentric HHV8-positive Castleman's disease: long-term complete remission by a combined chemo/radiation and interferon-a therapy regimen. Br J Haematol 103 (1998) 788-790
21. Wu J.J., Huang D.B., Pang K.R., Hsu S., and Tyring S.K. Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol 153 (2005) 254-273